Pulmonary Disease, Chronic Obstructive Patients Admitted in Emergency Department for Acute Exacerbation Clinical Trial
Official title:
Usefulness of Pro-adrenomedullin (MR proADM)as a Predictor of Outcome in Acute Exacerbations of COPD Visiting the Emergency Room
The purpose of this study is to determine whether pro-adrenomedullin (Mr proADM)in addition to clinical evaluation is effective to predict outcome of acute exacerbations of COPD patients visiting the emergency room(ER).
Acute exacerbation of COPD (AECOPD)are usual and frequent cause of admission in emergency
room (ER). No validated clinical or biological predictor of evolution are available.
The main objective is to determine the prognosis value of Mr proADM in addition to the
clinical risk stratification for AE COPD patients in ER.
Patients presenting with a AECOPD diagnosis in ER will have a blood sample collected and
freezed at their admission. Mr proADM will be assessed at the end of the study. Clinicians
in charge of patients will not have the result during the management of their patients. This
study implies no change in the patients' management.
Data related to the patients'demographic,current exacerbation and basic COPD characteristics
will be collected.
;
Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic